Third Harmonic Current Valuation vs. Return On Asset
| THRD Stock | USD 12.76 0.35 2.67% |
For Third Harmonic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Third Harmonic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Third Harmonic Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Third Harmonic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Third Harmonic Bio over time as well as its relative position and ranking within its peers.
Third |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Third Harmonic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Third Harmonic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Third Harmonic Bio Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Third Harmonic's current stock value. Our valuation model uses many indicators to compare Third Harmonic value to that of its competitors to determine the firm's financial worth. Third Harmonic Bio is rated fifth in current valuation category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Third Harmonic by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Third Current Valuation vs. Competition
Third Harmonic Bio is rated fifth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 12.19 Billion. Third Harmonic holds roughly 298.03 Million in current valuation claiming about 2.44% of equities under Health Care industry.
Third Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Third Harmonic |
| = | 298.03 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Third Harmonic |
| = | -0.11 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Third Return On Asset Comparison
Third Harmonic is currently under evaluation in return on asset category among its peers.
Third Harmonic Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Third Harmonic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Third Harmonic will eventually generate negative long term returns. The profitability progress is the general direction of Third Harmonic's change in net profit over the period of time. It can combine multiple indicators of Third Harmonic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts. Third Harmonic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Third Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Third Harmonic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Third Harmonic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Third Harmonic's important profitability drivers and their relationship over time.
Use Third Harmonic in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Third Harmonic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will appreciate offsetting losses from the drop in the long position's value.Third Harmonic Pair Trading
Third Harmonic Bio Pair Trading Analysis
The ability to find closely correlated positions to Third Harmonic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Third Harmonic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Third Harmonic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Third Harmonic Bio to buy it.
The correlation of Third Harmonic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Third Harmonic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Third Harmonic Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Third Harmonic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Third Harmonic position
In addition to having Third Harmonic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
To fully project Third Harmonic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Third Harmonic Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Third Harmonic's income statement, its balance sheet, and the statement of cash flows.